Vanda Pharmaceuticals | VNDA - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Insmed USD 73.38M 6.53M 2026-03
J&J USD 10.46B 1.53B 2026-03
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 161M 156M 2026-03
Novartis USD 4.46B 99M 2025-12
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Takeda JPY 491.34B 23.75B 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Veracyte USD 6.91M 2.32M 2026-03